LPA-话题@MedSci

#LPA#

22篇内容 | 1007人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1581402, encodeId=34a215814021d, content=<a href='/topic/show?id=c0c9110333d' target=_blank style='color:#2F92EE;'>#LPA#</a>, objectTitle=NEJM：Sofosbuvir和Velpatasvir治疗HCV感染有较高的病毒学应答率, objectType=article, longId=58934, objectId=42b75893460, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42b75893460, replyNumber=0, likeNumber=26, createdTime=2015-11-18, rootId=0, userName=ms9474365431325850, userId=9a7b16794085, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42b75893460, moduleTitle=NEJM：Sofosbuvir和Velpatasvir治疗HCV感染有较高的病毒学应答率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42b75893460)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581401, encodeId=67f31581401b5, content=<a href='/topic/show?id=c0c9110333d' target=_blank style='color:#2F92EE;'>#LPA#</a>, objectTitle=J Cardiol：ALPACS研究结果出人意料非ST抬高心梗介入术前负荷他汀无获益, objectType=article, longId=50491, objectId=753950491ed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=753950491ed, replyNumber=0, likeNumber=19, createdTime=2015-05-10, rootId=0, userName=ms9474365431325850, userId=9a7b16794085, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=753950491ed, moduleTitle=J Cardiol：ALPACS研究结果出人意料非ST抬高心梗介入术前负荷他汀无获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=753950491ed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1581400, encodeId=b4c31581400e3, content=<a href='/topic/show?id=c0c9110333d' target=_blank style='color:#2F92EE;'>#LPA#</a>, objectTitle=CIR：LPA可能是肿瘤细胞免疫逃避的“隐身衣”, objectType=article, longId=26037, objectId=3d722603e98, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3d722603e98, replyNumber=0, likeNumber=38, createdTime=2013-11-02, rootId=0, userName=ms9474365431325850, userId=9a7b16794085, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d722603e98, moduleTitle=CIR：LPA可能是肿瘤细胞免疫逃避的“隐身衣”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d722603e98)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

LPA

2020-05-29

ms9474365431325850 (审核中...)

前往app查看评论内容

#LPA#

NEJM：Sofosbuvir和Velpatasvir治疗HCV感染有较高的病毒学应答率

2015-11-18

ms9474365431325850 (审核中...)

前往app查看评论内容

#LPA#

J Cardiol：ALPACS研究结果出人意料非ST抬高心梗介入术前负荷他汀无获益

2015-05-10

ms9474365431325850 (审核中...)

前往app查看评论内容

#LPA#

CIR：LPA可能是肿瘤细胞免疫逃避的“隐身衣”

2013-11-02

科室
- - 订阅+
  - 更多科室
工具
服务